前药
药物输送
化学
药品
超分子化学
PARP抑制剂
抗药性
支柱
癌症研究
DNA
药理学
聚ADP核糖聚合酶
生物化学
聚合酶
生物
微生物学
结晶学
晶体结构
工程类
有机化学
结构工程
作者
Manman Yang,Ke Yang,Bingling Gao,Peng Wang,Tianjiao Li,Yi Zheng,Yuxin Pei,Zhichao Pei,Yinghua Lv
摘要
A supramolecular nano-delivery system GP5⊃Pro-ANI based on the host-guest complex of glycosylated pillar[5]arene (GP5) and an amide linked fluorescent PARP inhibitor (4-amino-1,8-naphthimide, ANI) was constructed. The PARP inhibitor ANI, capable of inhibiting the ability of DNA damage repair, was modified into an AIE prodrug (Pro-ANI), which allows for the visualization of real-time cancer cellular drug uptake tracing and selective drug release. In vitro studies revealed that the DOX-loaded GP5⊃Pro-ANI achieved targeted drug delivery and dual-drug synergistic chemotherapy for DNA repair interference and tumor DNA collapse aggravation, which enhanced the chemosensitivity and overcame tumor drug resistance and migration. This strategy paves a new avenue for utilizing PARP inhibitors to construct AIE supramolecular nano-delivery systems for drug uptake visualization and synergistic chemotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI